Aehr Test Systems (NASDAQ:AEHR – Get Free Report) shares hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $131.17 and last traded at $130.3270, with a volume of 1104845 shares changing hands. The stock had previously closed at $117.18.
More Aehr Test Systems News
Here are the key news stories impacting Aehr Test Systems this week:
- Positive Sentiment: Aehr received a $22 million follow-on order from its lead customer for wafer-level burn-in systems used with advanced AI training and inference processors. The repeat order supports demand for Aehr’s FOX systems and strengthens the company’s position in AI and high-performance computing. Aehr Receives $22 Million Follow-on Order
- Positive Sentiment: Recent updates highlighted record quarterly bookings of $60.7 million, an approximately $100.6 million backlog and fiscal 2027 revenue guidance of $130 million to $150 million. These figures provide stronger revenue visibility and reinforce the growth opportunity from AI-chip testing. Aehr’s AI Order and WLBI Opportunity
- Neutral Sentiment: CEO Gayn Erickson and CFO Chris Siu are scheduled to meet investors at the Needham Virtual Semiconductor and SemiCap 1×1 Conference on August 19. The event could offer additional insight into demand, backlog conversion and fiscal 2027 execution, although no new financial information was announced. Aehr to Participate in Needham Conference
- Negative Sentiment: Insiders sold a combined 65,130 shares worth approximately $8.5 million on August 12. The sales included 40,000 shares from the CEO, 15,000 from the COO and additional shares from two directors. While the executives retained sizable positions, the transactions may encourage profit-taking and add selling pressure after the stock’s rapid advance. Aehr CEO Stock Sale Filing
- Negative Sentiment: Analyst commentary warns that AEHR now carries demanding expectations following its major gains. Its elevated valuation and negative earnings multiple leave the stock vulnerable to further declines if AI-related orders slow, backlog conversion disappoints or execution falls short.
Analysts Set New Price Targets
Several analysts recently weighed in on the stock. Craig Hallum reaffirmed a “buy” rating and issued a $125.00 target price on shares of Aehr Test Systems in a report on Wednesday, July 15th. Zacks Research raised shares of Aehr Test Systems from a “hold” rating to a “strong-buy” rating in a research report on Friday, July 17th. Weiss Ratings lowered shares of Aehr Test Systems from a “sell (d)” rating to a “sell (e+)” rating in a report on Wednesday, July 29th. Jefferies Financial Group assumed coverage on shares of Aehr Test Systems in a research report on Thursday. They set a “buy” rating and a $175.00 price objective for the company. Finally, Lake Street Capital reiterated a “buy” rating and set a $110.00 target price on shares of Aehr Test Systems in a research note on Wednesday, July 15th. Two investment analysts have rated the stock with a Strong Buy rating, four have assigned a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Aehr Test Systems currently has an average rating of “Buy” and a consensus target price of $136.67.
Aehr Test Systems Price Performance
The company’s 50 day simple moving average is $92.12 and its 200 day simple moving average is $71.00. The company has a market capitalization of $4.02 billion, a PE ratio of -513.73 and a beta of 3.10.
Insider Transactions at Aehr Test Systems
In other Aehr Test Systems news, Director Howard T. Slayen sold 20,000 shares of the company’s stock in a transaction on Tuesday, August 4th. The shares were sold at an average price of $108.30, for a total value of $2,166,000.00. Following the completion of the transaction, the director owned 146,367 shares in the company, valued at $15,851,546.10. This represents a 12.02% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Rhea J. Posedel sold 8,413 shares of the company’s stock in a transaction on Wednesday, August 12th. The shares were sold at an average price of $130.00, for a total transaction of $1,093,690.00. Following the completion of the transaction, the director owned 387,962 shares of the company’s stock, valued at $50,435,060. This represents a 2.12% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 88,130 shares of company stock worth $10,997,361. Insiders own 6.80% of the company’s stock.
Institutional Trading of Aehr Test Systems
Several institutional investors and hedge funds have recently made changes to their positions in AEHR. BlackRock Inc. purchased a new position in Aehr Test Systems during the 2nd quarter worth approximately $255,476,000. Connor Clark & Lunn Investment Management Ltd. purchased a new stake in Aehr Test Systems in the second quarter valued at approximately $64,433,000. Wellington Management Group LLP lifted its stake in Aehr Test Systems by 129.9% in the fourth quarter. Wellington Management Group LLP now owns 830,664 shares of the semiconductor company’s stock valued at $16,771,000 after buying an additional 469,400 shares during the last quarter. Invesco Ltd. boosted its holdings in shares of Aehr Test Systems by 1,137.2% in the third quarter. Invesco Ltd. now owns 366,570 shares of the semiconductor company’s stock valued at $11,037,000 after acquiring an additional 336,940 shares during the period. Finally, Next Century Growth Investors LLC grew its position in shares of Aehr Test Systems by 99.9% during the fourth quarter. Next Century Growth Investors LLC now owns 552,506 shares of the semiconductor company’s stock worth $11,155,000 after acquiring an additional 276,160 shares during the last quarter. 69.69% of the stock is owned by hedge funds and other institutional investors.
About Aehr Test Systems
Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.
The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.
Further Reading
- Five stocks we like better than Aehr Test Systems
- Why Are Analysts Freaking Out About Apple’s All-Glass iPhone?
- Asian Market Circuit Breakers Hit Stocks, Not AI Demand
- Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
- Nebius Just Exploded 34% on Blowout Earnings—Is It Time to Buy?
Receive News & Ratings for Aehr Test Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aehr Test Systems and related companies with MarketBeat.com's FREE daily email newsletter.
